Respiratory syncytial virus (RSV) vaccination will be offered to adults aged 80 and over in England, and to all residents in care homes for older people, starting April 1st. The expansion adds to the ...

The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in their lifetimes, ...

In a large study of 429,595 adults aged 65 years or older, adjuvanted and high-dose influenza vaccines showed no significant ...

RSV vaccines showed initial high effectiveness, but protection decreased over 18 months, especially in immunocompromised individuals. The study used VHA data to evaluate vaccine effectiveness in ...

As people age, their immune defenses gradually weaken, a biological process known as immunosenescence. That decline leaves older adults disproportionately vulnerable to infections that younger people ...

As flu season approaches and there is a push for vaccination, a study by Allen Institute scientists has uncovered why vaccines can trigger a weaker response in older adults—aged about 65 years—and ...

As the days grow longer, it's natural to start to get excited for a light at the end of the cold/flu/RSV/COVID-19 tunnel. Hope springs eternal as the calendar flips to March. And we probably don't ...

Public health, explained: Sign up to receive Healthbeat’s free national newsletter here. Let’s be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% ...

Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found. By Paula Span Let’s be clear. The primary reason to be vaccinated against shingles is that two ...

Let’s be clear: The primary reason to be vaccinated against shingles is that two shots provide at least 90% protection against a painful, blistering disease that a third of Americans will suffer in ...